Based on the information available, it is difficult to definitively say whether Wegovy is a more cost-effective option than Ozempic as it depends on various factors such as dosage, treatment duration, and insurance coverage. However, we can compare the list prices of these drugs.

Wegovy (semaglutide) is a prescription medication used for weight management, while Ozempic (also semaglutide) is used to improve blood sugar control in adults with type 2 diabetes. Although they contain the same active ingredient, they are approved for different indications and have different FDA-approved dosages.

According to DrugPatentWatch.com [1], as of October 2021, the list price for Ozempic is around $830 for a 30-day supply of the 1mg dose, while Wegovy's list price is around $1,350 for a 30-day supply of the 2.4mg dose. It is important to note that these prices are subject to change and may vary based on the pharmacy and insurance coverage.

Therefore, based on list prices, Wegovy appears to be more expensive than Ozempic. However, without considering factors such as treatment duration, dosage, and insurance coverage, it is challenging to make a direct cost-effectiveness comparison between the two drugs. It is recommended to consult with a healthcare provider or pharmacist for personalized advice on cost and treatment options.

Sources:
[1] DrugPatentWatch.com - Semaglutide (Ozempic, Rybelsus, Wegovy) - <https://www.drugpatentwatch.com/drugs/semaglutide>